Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient

S. Mohammadiam, S. M. Mirsaeidi, A. Ostad Rahimi, S. Shaghasempour, J. Baghdadchi, F. Mohammadi, M. Amiri, P. Tabarsi, S. D. Mansouri, M. R. Masjedi (Tabriz, Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2005 - Biology of tuberculosis
Session: Biology of tuberculosis
Session type: Thematic Poster Session
Number: 4147
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Mohammadiam, S. M. Mirsaeidi, A. Ostad Rahimi, S. Shaghasempour, J. Baghdadchi, F. Mohammadi, M. Amiri, P. Tabarsi, S. D. Mansouri, M. R. Masjedi (Tabriz, Tehran, Islamic Republic Of Iran). Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient. Eur Respir J 2005; 26: Suppl. 49, 4147

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 455s
Year: 2005

Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019


Nutritional deficiency in patients with pulmonary tuberculosis
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021


Evaluating the nutritional status in active pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 427s
Year: 2005

Clinical profile and outcome of complicated pulmonary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 362s
Year: 2002

Nutritional status survey in pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 689s
Year: 2005

Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis
Source: Eur Respir J 2006; 28: Suppl. 50, 13s
Year: 2006

Clinical characteristics of paradoxical response to chemotheraphy in pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Iron status in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 427s
Year: 2005

Tuberculin hypersensitivity and its relation to nutritional status in patients with active pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010


Biochemical portrait of patients with different course of pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 645s
Year: 2004

The profile of patients with pulmonary and extrapulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001

Immunological criterions of the pulmonary tuberculosis progression
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008

Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 86s
Year: 2007

Vitamin C levels in Indian patients with active pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010


Vitamin supplement-therapy and lipid hyper oxidation marker in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005

Analysis of the pulmonary tuberculosis patients social status
Source: Eur Respir J 2004; 24: Suppl. 48, 191s
Year: 2004

Enhanced clinical improvement in pulmonary tuberculosis patients with antioxidant supplementation: a preliminary report
Source: Eur Respir J 2003; 22: Suppl. 45, 40s
Year: 2003

Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Assessment of COVID-19 impact on the course of pulmonary tuberculosis
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021